Search Results 1061-1070 of 2679 for Mão Morta de Volkmann
Title: Tailoring Recruitment Communication Using Virtual Human Technology to Increase Participation of Older Minority Adults in Clinical Trials
The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose combination for subcutaneous ...
Bone marrow diagnosis of chronic myeloid neoplasms, such as myelodysplastic syndromes and chronic myelomonocytic leukemia. Minimal residual disease assessment ...
Publications · Yamashita R, Kapoor T, Alam MN, Galimzianova A, Syed SA, Ugur Akdogan M, Alkim E, Wentland AL, Madhuripan N, Goff D, Barbee V, Sheybani ND, ...
... Mao Q, Flanagan ME, Castellani RJ, Khurana V, Ndayisaba A, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Moore A, Norcliffe-Kaufmann L, Palma JA ...
Rochester, Minn. The trial is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) ...
Bangalore Kumar A, Peters MS, Jakub JW, Harmsen W, Baum CL. Primary cutaneous melanoma features predict development of in-transit metastases/satellite lesions: ...
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved ...
RATIONALE: Giving chemotherapy before an autologous stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. After ...
John C. Matulis, III, D.O., M.P.H. · Internist · Public Health and General Preventive Medicine Specialist.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.